US Patent 9885086 Phospholipase C gamma 2 and resistance associated mutations
Patent 9885086 was granted and assigned to Pharmacyclics on February, 2018 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 9885086 Phospholipase C gamma 2 and resistance associated mutations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
